Om

Vector Science and Therapeutics Corp. is a biotechnology company focused on developing novel biomechanical devices and active localized drug delivery platforms. These technologies enable clinicians to provide site-directed, non-systemic interventions for non-narcotic pain management, musculoskeletal tissue regeneration, and precision treatments where systemic risks are unacceptable. The company specializes in active transdermal drug delivery systems and innovative catheter-based platforms, including a recent provisional patent for intratumoral drug delivery targeted at pancreatic cancer research. Its product pipeline equips medical professionals with tools to improve clinical outcomes, reduce treatment burdens for patients and payers, and support personalized medicine through patient journey insights. Vector Science and Therapeutics Corp. operates in the pharmaceuticals and biotech sector, advancing commercialization of these platforms to address critical needs in pain management and oncology. Headquartered in Mequon, Wisconsin, United States, the company emphasizes technologies that enhance the practice of medicine with localized precision therapies.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I VECTOR SCIENCE AND THERAPEUTICS MED ENDAVU: Køb Vector Science and Therapeutics ($PAIN) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Vector Science and Therapeutics, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.